09.12.2018
Improve Outcomes
$513,817.00
30 months
Glucose Responsive Glucagon - Glucose Sensing Nanogels
Development of a novel glucose responsive glucagon therapy that could improve glucose control and reduce the chance of hypoglycemia for people with Type 1 Diabetes.